Cargando…

Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)

BACKGROUND: Elevated levels of low-density lipoprotein cholesterol (LDL-C) and glycosylated hemoglobin (HbA1c) are risk factors for cardiovascular complications. This study evaluated LDL-C goal attainment in Russian clinical practice among patients with moderate to very high cardiovascular risk. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boytsov, Sergey, Logunova, Natalia, Khomitskaya, Yunona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732396/ https://www.ncbi.nlm.nih.gov/pubmed/29246151 http://dx.doi.org/10.1186/s12933-017-0641-4

Ejemplares similares

Centralized Pan-Middle East Survey on the Under-Treatment of Hypercholesterolemia: Results from the CEPHEUS II Study in Egypt
por: Reda, Ashraf, et al.
Publicado: (2017)

Centralized Pan-Middle East Survey on the Under-Treatment of Hypercholesterolemia: Results from the CEPHEUS Study in Egypt
por: Reda, A., et al.
Publicado: (2014)

PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia
por: Karpov, Yuri, et al.
Publicado: (2015)

Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study
por: Boytsov, Sergey A., et al.
Publicado: (2021)

The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study
por: Meshkov, Alexey N., et al.
Publicado: (2021)

Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS study
por: Al-Zakwani, Ibrahim, et al.
Publicado: (2016)

CEPHEUS SA: a South African survey on the under-treatment of hypercholesterolaemia
por: Raal, Frederick Johan, et al.
Publicado: (2011)

The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF
por: Ershova, Alexandra I., et al.
Publicado: (2017)

Underidentification and Undertreatment Issues
por: Bottorff, Michael B.
Publicado: (2003)

Undertreatment of breast cancer in the elderly
por: Rocco, Nicola, et al.
Publicado: (2013)

Older breast cancer undertreatment: unconscious bias to undertreat—potential role for the international geriatric radiotherapy group?
por: Nguyen, Nam P., et al.
Publicado: (2020)

Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
por: Al-Zakwani, Ibrahim, et al.
Publicado: (2018)

Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022)

Real-World Data to Identify Hypercholesterolemia Patients on Suboptimal Statin Therapy
por: Kajinami, Kouji, et al.
Publicado: (2019)

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study-
por: Nohara, Atsushi
Publicado: (2022)

In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery
por: Kaban, Alpaslan, et al.
Publicado: (2019)

Retraction Note: Undertreatment of breast cancer in the elderly
por: Rocco, Nicola, et al.
Publicado: (2016)

Extensive undertreatment of osteoporosis in older Swedish women
por: Lorentzon, M., et al.
Publicado: (2019)

Underrepresentation and undertreatment of women in hematology: An unsolved issue
por: Liblik, Kiera, et al.
Publicado: (2022)

Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study
por: Rapeport, Naomi, et al.
Publicado: (2013)

Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing
por: Miroshnikova, Valentina V., et al.
Publicado: (2021)

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
por: Banach, Maciej, et al.
Publicado: (2020)

Calprotectin instability may lead to undertreatment in children with IBD
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2020)

Excess Mortality and Undertreatment of Women With Severe Aortic Stenosis
por: Tribouilloy, Christophe, et al.
Publicado: (2020)

Russian Doll Genes and Complex Chromosome Rearrangements in Oxytricha trifallax
por: Braun, Jasper, et al.
Publicado: (2018)

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
por: Ershova, Alexandra I., et al.
Publicado: (2016)

Underdiagnosis and undertreatment of asthma in children: a tertiary hospital's experience
por: Vasilopoulou, Ioanna, et al.
Publicado: (2015)

Undertreatment of Osteoporosis Following Hip Fractures in Jeju Cohort Study
por: Kim, Sang-Rim, et al.
Publicado: (2014)

Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care
por: Morgado, Afonso, et al.
Publicado: (2019)

Underscreening and undertreatment? Periodontal service provision in very old Germans
por: Krois, Joachim, et al.
Publicado: (2020)

The Undertreatment of Gallbladder Cancer: Gaps in Seeking, Reaching, and Receiving Care
por: Keilson, Jessica M., et al.
Publicado: (2021)

Editorial: Genetics of familial hypercholesterolemia: New insight—Volume II
por: Vuorio, Alpo, et al.
Publicado: (2022)

Prevalence of Myopic Maculopathy Among Adults in a Russian Population
por: Bikbov, Mukharram M., et al.
Publicado: (2020)

Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction
por: Cui, Yuxia, et al.
Publicado: (2019)

The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II): - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis -
por: Shiomi, Masashi
Publicado: (2020)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

A Low Rivaroxaban Plasma Level May Indicate Anticoagulation Undertreatment
por: Romano, Simone Lorenzo, et al.
Publicado: (2018)

Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment
por: Olivier, Timothée, et al.
Publicado: (2022)

Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
por: Henrysson, Josefin, et al.
Publicado: (2022)

Trends and Costs Associated With Suboptimal Physical Activity Among US Women With Cardiovascular Disease
por: Okunrintemi, Victor, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_90tth07giq1ss2533gdf077n35